Found 7 matching trials
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIBĀ® Concomitantly Given With Engerix BĀ® Paediatric and OPV PHASE3 The purpose of this study is to document the immunological response to the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib⢠and OPV Given at Age 2, 4, and 6 Months. PHASE3 To demonstrate that DTaP-IPV-HB-PRP\~T combined vaccine does not induce a h...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants PHASE3 DTaP-HB-PRP\~T combined vaccine is being developed in order to comply with ...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hibā¢, Both Given Concomitantly With Oral Polio Vaccine PHASE3 The purpose of this study is to support the registration of the pentavalent...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa PHASE3 This open label randomized study will be conducted to evaluate and/or descr...
Show More Location
Investigational Site Number : 3560006
Learn More & Join Trial
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hibā¢, Concomitantly With OPV in Healthy Infants PHASE3 This is a study to compare the safety and immune response of a pentavalent ...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib⢠PHASE3 The present trial is a follow-up of AL203 study (NCT00343889).
Primary Obj...
Show More Location
Multiple Locations
Learn More & Join Trial